HLA-DQB1 allele polymorphism and clinical characteristics of 15 familial myasthenia gravis cases in north China

Chinese Journal of Medical Genetics

Volumn 23, Issue 4, 2006, Pages 437-439

  Yang, Hong Wei ^a   Sun, Zhao Lin ^b   Zhang, Ming Yi ^a   Wang, Shu Hui ^c   Li, Hai Feng ^b   Cong, Zhi Qiang ^b   Gao, Xiao Yu ^d   Xie, Yan Chen ^d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphism; Genetic susceptibility; Human leukocyte antigen DQB1; Myasthenia gravis, family

Indexed keywords

HLA DQB1 ANTIGEN;

ALLELE; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL DISEASE; GENE FREQUENCY; HUMAN; MYASTHENIA GRAVIS; POLYMERASE CHAIN REACTION; STUDENT T TEST;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 33747707451     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Xu XH. Myasthenie. 1st ed. Beijing: Peking Union Medical College Press, 2003.24-95.
2. Bergoffen J, Zmijewski CM, Fischbeck KH. Familial autoimmune myasthenia gravis. Neurology, 1994, 44:551-554.
3. Szobor A. Myasthenie gravis: familial occurrence in a study of 1100 myasthenia gravis patients. Acta Med Hung, 1989, 46:13-21.
4. Xing A, Yang HW, Wang SH. Polymorphism in HLA-DQB1 and genetic susceptibility to myasthenia gravis in north China. Shan Dong Med J, 2004, 44:26-27.
5. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP). Hum Immunol, 1993, 37:201-206.
6. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens, 1993, 41:119-134.
7. Tan JM, Zhou YC, Zhou XD. Tissue matching tech clinical application. Beijing: People's Medical Publishing House, 2002.96-98.
8. Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, et al. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand, 1999, 100:168-174.
9. Chitnis T, Khoury SJ. 20. Immunologic neuromuscular disorders. J Allergy Clin Immunol, 2003, 111(Suppl 2):S659-S68.
10. Vincent A, Palace J, Hilton-Jones D, et al. Myasthenia gravis. Lancet, 2001, 357:2111-2128.
11. Wang SH, Sun ZL, Cong ZQ, et al. Clinical features and HLA-DQA1 polymorphism in familial myasthenia gravis. Chin J Neurol, 2005, 38:91-94.
12. Li F, Szobor A, Croxen R, et al. Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci. Int J Mol Med, 2001, 7:289-294.
13. Tan JH, Ho KH. Familial autoimmune myasthenia gravis. Singapore Med J, 2001, 42:178-179.